MYX mayne pharma group limited

"Mayne reported $31 million underlying earnings before interest,...

  1. 1,302 Posts.
    lightbulb Created with Sketch. 87
    "Mayne reported $31 million underlying earnings before interest, tax and depreciation for the first half on February 26 (five days after signing its scheme implementation deed with Cosette). It told shareholders it “expects to grow underlying EBITDA in the second half of the 2025 financial year via revenue growth and cost leverage”.While it’s a bit of a choose-your-own adventure outlook statement, it suggested at least $62 million EBITDA for the full year to June 30 and was a big upgrade to analysts’ forecasts. "

    If I'm reading this correctly MYX stated it expects to grow EBITDA .... via revenue growth and cost leverage.

    Assumptions were made that would equate to at least $ 62 million ... but this figure was not stated by MYX>

    ??
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.20
Change
0.150(2.97%)
Mkt cap ! $422.4M
Open High Low Value Volume
$5.05 $5.24 $5.04 $2.929M 567.2K

Buyers (Bids)

No. Vol. Price($)
2 15203 $5.18
 

Sellers (Offers)

Price($) Vol. No.
$5.22 631 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.